STOCK TITAN

Insider 10b5-1 sales and RSU/PSU listings at ISRG (ISRG)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mark Brosius reported insider sales under 10b5-1 plans and listed planned dispositions of equity awards. The excerpt shows three 10b5-1 sales in December 2025: 4,500, 464, and 312 shares, with proceeds of $2,463,120.00, $254,499.36, and $170,776.32 respectively. It also lists 2,154 Restricted Stock Units dated 02/10/2026 and 1,173 Performance Stock Units dated 02/28/2026 as securities to be sold.

Positive

  • None.

Negative

  • None.

Insights

Filed 10b5-1 sales by an individual with recent December 2025 transactions and upcoming RSU/PSU dispositions.

Records show three executed 10b5-1 sales in December 2025 totaling 5,276 shares sold for aggregate proceeds shown across the three trades. The filing lists planned sales of 2,154 Restricted Stock Units and 1,173 Performance Stock Units with grant dates in February 2026.

Timing and cash‑flow treatment are governed by the 10b5‑1 instruction and award terms; the excerpt does not state who will receive proceeds from the RSU/PSU dispositions. Subsequent filings would clarify settlement mechanics and any remaining holder limits.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What 10b5-1 sales did ISRG insider Mark Brosius report?

The filing shows three 10b5-1 sales in December 2025 totaling 5,276 shares. Specifically, sales of 4,500; 464; and 312 shares occurred on 12/12/2025 and 12/15/2025, with proceeds listed for each transaction in the excerpt.

Does the excerpt list any upcoming equity awards to be sold for ISRG?

Yes. The excerpt lists 2,154 Restricted Stock Units dated 02/10/2026 and 1,173 Performance Stock Units dated 02/28/2026 as securities to be sold. The filing provides counts and grant dates for those awards.

How much cash did Mark Brosius receive from the December 2025 sales?

The excerpt shows proceeds of $2,463,120.00, $254,499.36, and $170,776.32 for the three December 2025 transactions. These amounts correspond to the 4,500; 464; and 312 share sales listed in the excerpt.

Were the December 2025 sales executed under a trading plan?

Yes. The excerpt identifies the December 2025 transactions as 10b5-1 Sales. The filing text attributes the trades to prearranged 10b5-1 plans for Mark Brosius and lists the trade dates and amounts accordingly.

Who is listed as the broker or intermediary in the filing?

The excerpt lists Morgan Stanley Smith Barney LLC Executive Financial Services with an address at 1 New York Plaza. That broker information appears in the filer/issuer section of the excerpt.
Intuitive Surgical Inc

NASDAQ:ISRG

ISRG Rankings

ISRG Latest News

ISRG Latest SEC Filings

ISRG Stock Data

176.65B
352.22M
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
SUNNYVALE